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INTRODUCTION
Breath holding spells are dramatic, involuntary episodes that occur in otherwise 
healthy children. These episodes are often frightening to parents until the situation is 
defused  by  explanation  and  reassurance.  The  attacks  are  self  limited  and  usually 
outgrown by school age.
BHS are  a  well  recognised  common problem affecting  about  27% of  healthy 
children1. Childhood breath holding conjures up an image of a stubborn toddler wilfully 
holding his breath until he gets what he wants. The reality is quite different however.
Two main types of BHS were described by Lombroso & Lerman2 – the cyanotic 
and pallid forms, according to the skin colour changes occurring during the episodes. 
Pallid BHS result from exuberant vagally mediated cardiac inhibition. Cyanotic BHS are 
of more complex pathogenesis, involving an interplay among hyperventilation, valsalva 
maneuver,  expiratory  apnea and intrinsic  pulmonary  mechanisms.  The  history  is  the 
mainstay of diagnosis; videotape documentation may be possible.3
The  age  of  onset  is  generally  below  18  months4,  5.  Breath  holding  is  not 
infrequently observed in the early weeks of life and has been described in the early 
newborn period also5,6. Usually cyanotic BHS begin between a child’s neonatal period 
and 18 m of age. For pallid BHS, the age of onset is 12 m to 24m. By 24 m, almost all 
children who experience breath holding will have had their first episode.
Boys and girls  appear equally susceptible5.  Attacks are usually precipitated by 
situations associated with anger, frustration or agitation. Pain and fear may also be the 
inciting factors.
The frequency of attacks varies greatly, ranging from very occasional attacks to 
several times a day. The greatest frequency of events tends to be in the second year of 
life. More commonly, patients have several episodes a week, and overall occurrences 
ranges from daily to monthly. By the time patients are 4 yrs old, about half of BHS cases 
have spontaneously resolved;  by age 6 about 90% have done so;  and by 7 or 8 yrs 
virtually all have resolved2,7.
Most of the children are neurologically and intellectually normal, but associated 
behavioural problems are common. However these behaviour disturbances are in no way 
characteristic.5
CYANOTIC ATTACKS
This is the most common type of BHS. Anger, frustration and painful stimuli such 
as a fall are common triggers. After such a stimulus, the child cries, stops breathing in 
expiration, and becomes cyanosed, limp and unconscious. In the shorter attacks he/ she 
gains consciousness within a few minutes and may resume crying. If apnea lasts longer, 
the limp phase is followed by an ophisthotonic phase, sometimes with clonic movements 
of the limbs and sometimes incontinence of urine or faeces. This clonic phase may be 
followed by another limp phase before consciousness is regained.2
PALLID ATTACKS
These  are  termed  ‘reflex  anoxic  seizures’  by  Stephenson  (1978)7.  The  pallid 
attack  comes  on  a  few  seconds  after  a  sudden  unexpected  and  mildly  unpleasant 
stimulus.  This is  often a moderate  or  mild knock on the back of  the head,  the first 
experience of a bath or a new taste which may surprise and upset the child. He gasps and 
becomes apneic and unresponsive, usually without significant crying; he is limp, deathly 
pale and seems to his parents to be dead, but usually returns fairly rapidly to normal, 
although he may  sleep  afterwards.  However  it  is  common for  ophisthotonus,  a  few 
clonic movements and upturning of eyes to occur.
Although  it  is  a  much  less  likely  scenario,  BHS  may  be  secondary  to  CNS 
malformations,  such as Arnold- Chiari  malformation7.  Spells may be associated with 
developmental disorders such as Rett syndrome or with Riley- Day syndrome, a familial 
dysautonomia.7  Sporadic  reports  have  linked  BHS  with  underlying  hematologic 
abnormalities including transient  erythroblastopenia of childhood and iron deficiency 
states9,10. In the latter case, treatment with iron supplements was found to significantly 
reduce the number of spells10.
AETIOPATHOGENESIS
The aetiology of BHS is not yet clear. Some workers have related its origin to the 
child’s  temperament11,  parental  attitudes11,  iron  deficiency2,12,  or  constitutional 
hypervagotonia1.  Recently DiMario F.J. Jr has shown that autonomic nervous system 
dysfunction is the basic underlying pathology in children with BHS13,14. The study by 
Anil  B.G.  et  al.,  in  India  showed  that  subtle  underlying  autonomic  nervous  system 
dysregulation was present in children with BHS15.
MECHANISMS POSTULATED
Emotional  factors are certainly involved. The attacks are most frequent during 
normal developmental phase of negativism. Many of the affected children are described 
by their parents as being demanding and rather stubborn children4.
Hereditary  and familial  factors  are  also important.  Previous  observations have 
noted that perhaps 20–30 % of children with benign BHS have family members who are 
affected during their childhood7,16. In addition, data from detailed analysis suggest an 
autosomal  dominant  mode  of  inheritance  in  some  cases  of  severe  BHS16.  Vulliamy 
(1956) suggested that the basic mechanism was an acute reduction in cerebral blood 
flow produced by a sharp rise in intrathoracic pressure or valsalva like maneuver caused 
by breath holding in expiratory phase. The initial hyperventilation caused hypocapnia 
and  this  caused  cerebral  vasoconstriction.  Then,  when  breath  was  suddenly  held  in 
expiration,  the  increased  intrathoracic  pressure  causes  a  decrease  in  the  effective 
perfusion pressure in cerebral arteries by increasing the jugular venous pressure and/ or 
decreasing carotid artery pressure4.
Lombroso & Lerman2 proposed that the two types of BHS are caused by two 
different mechanisms. In the cyanotic BHS, they agreed with the mechanism suggested 
by Vulliamy. In the pallid BHS, they thought that there was sudden circulatory failure 
secondary to cardiac asystole. In both types of BHS, acute cerebral anoxia was the end 
result and was responsible for the loss of consciousness. They also demonstrated marked 
generalised slowing of activity in the EEG during the early hypoxic stage of the attack. 
It  was followed by flattening of the record if  the attack was prolonged and cerebral 
anoxia supervened. They suggested that electrical silence in the EEG was probably due 
to cessation of cortical neuronal activity and that the stiffening, ophisthotonus and the 
tonic  seizures occasionally  seen in  the prolonged attacks were due to the release of 
brainstem structures from the control of corticoreticular inhibitory fibres.
Recently DiMario by his studies has shown that there is generalised autonomic 
dysfunction  in  children  with  BHS.  This  dysregulation  may  contribute  to  the 
pathophysiology of severe BHS in these children13,14.
Kohyama J et al., studied REM sleep in breath holders17. He performed one night 
polysomnography on seven subjects suffering from BHS, including one whose death 
was suggested to be the consequence of a breath holding spell. The average number of 
both REMs and bursts of REMs in REM sleep in the breath holders were significantly 
lower than those in age-matched controls. Since the rapid eye activity is generated in the 
brainstem, the authors hypothesised that a functional brainstem disturbance is involved 
in the occurrence of BHS.
Kahn et  al.,  investigated the possibility  that  infants  with breath holding spells 
have breathing disorders  during sleep18.  The infants  were studied during a one-night 
monitoring session and the 142 sleep recordings were analysed. The authors concluded 
that the obstructed breathing during both wakefulness and sleep could be related to a 
common immature breathing control.
ROLE OF IRON DEFICIENCY ANAEMIA IN BHS
Many authors9,10,19,20 have reported an association of iron deficiency anaemia with 
breath  holding  spells  and  improvement  with  iron  therapy.  The  age  of  onset  and 
presentation of spells occur during the period of maximum iron deficiency. As the child 
starts consuming diet with better iron content, the illness starts waning19.
It is not known how iron deficiency leads to BHS. Iron deficiency may lead to 
adverse effects on oxygen uptake in the lungs and reduces availability of oxygen to 
tissues,  including  the  central  nervous  system.  Iron  also  plays  an  important  role  in 
catecholamine metabolism and the functioning of neurotransmitters and enzymes in the 
CNS.  The  correction  of  spells  during  treatment  with  iron  may  be  related  to  the 
functional restoration of these neurotransmitters20.
Orii et al., evaluated the autonomic nervous system of patients with BHS after 
treatment with iron. They found that iron supplementation improves the dysregulation of 
the autonomic nervous system reflexes21.
PROPOSED MECHANISMS FOR THE OCCURRENCE OF BHS
1. Social and emotional factors4,11
2. Hereditary and familial factors7,11,16
3. Familial hypervagotonia1
4. Autonomic nervous system dysfunction13,14
5. Functional brainstem disturbances17
6. Iron deficiency9,10,19,20
PALLID BREATH HOLDING SPELLS
Unexpected/ unpleasant stimulus
Vagally mediated asystole
Sudden circulatory failure
Cerebral anoxia
CYANOTIC BREATH HOLDING SPELLS
Vigorous crying
Hyperventilation Hypocapnia
Breath held in expiration Cerebral vasoconstriction
Increased intrathoracic pressure
Increased JVP, decreased carotid artery pressure
Decreased cerebral perfusion pressure
CEREBRAL ANOXIA
MANAGEMENT
COUNSELLING AND BEHAVIOR MODIFICATION
It is important to assure the parents that although BHS are frightening to observe, 
they  are  benign  and  children  outgrow  them.  Also,  the  parents  should  be  told  that 
evidence  suggests  no serious  long term effects  of  benign BHS in otherwise  healthy 
children;  these  patients  don’t  have  increased  risk  of  epilepsy  or  other  neurologic 
problems. The only significant finding on subsequent follow up of children with BHS 
was a mildly increased incidence of syncope later in life,  especially in childhood or 
adolescence2. Later syncope is rare in children with cyanotic BHS, whereas it occurs in 
17%  of  children  with  pallid  BHS7.  Adequate  education  of  caregivers  about  BHS, 
alleviation of their anxiety about these episodes is essential. Because of fear parents may 
try to prevent every conflict or minor mishap in a child’s life. Such efforts are neither 
practical  nor  possible  and  may  lead  parents  to  overindulge  their  child  or  to  forego 
appropriate discipline to pacify him/her. Behaviour problems may ensue.
Nevertheless, when a child with BHS becomes upset or cries, reasonable efforts to 
calm the child or distract his attention should be made. If an episode occurs despite these 
measures,  observation  of  the child  and prevention of  injury are  generally  all  that  is 
required. If a child loses consciousness, he should be placed in left lateral position to 
avoid injury and possible aspiration. As he recovers he should be left to himself. The 
parents  should  display  an  attitude  of  unconcern  to  prevent  the  child  from  gaining 
satisfaction by his performance and using the attacks to dominate the family.
IRON THERAPY
Treatment of concomitant iron deficiency anaemia with ferrous sulphate (6mg/kg/
day) has been reported to decrease the frequency of spells10,20. Iron has also been found 
to reduce the autonomic nervous system dysfunction in children with BHS21.
ATROPINE
In severe cases with associated bradypnea or asystole or in patients with severe 
pallid BHS with multiple daily episodes, a 0.1 mg of oral atropine three times daily has 
been found to be effective in preventing pallid BHS. 
ANTICONVULSANTS
Various  drugs  such  as  diazepam,  sodium  valproate,  carbamazepine  and 
phenobarbitone  have  been used  for  the control  of  anoxic  seizures  in  breath  holding 
spells3,22,28. These drugs may be useful in control of seizures but there is no definitive 
evidence about their role in reduction of frequency or severity of breath holding spells. 
Diazepam is a benzodiazepine, with a high therapeutic index and is safe in children. It is 
a selective anxiolytic, hypnotic, muscle relaxant and anticonvulsant. It acts on the limbic 
system, and also reduces the hypersensitivity of the autonomic nervous system. It acts 
on  the  GABA-A  chloride  channel  receptor  complex  and  facilitates  the  action  of 
GABA29. Regular use of low dose diazepam for reduction of the frequency or severity of 
spells  has  not  been  studied  before.  Its  effect  on  the  temperament  and  aggressive 
behaviour of difficult children has led to its off-label use for the treatment of breath 
holding spells.
NEWER MODALITIES OF THERAPY
PIRACETAM
Piracetam is a newer anti epileptic drug. It enhances learning and memory. It acts 
on the cholinergic system in the cortex and hippocampus, and has a protective effect 
against cerebral hypoxia. It possesses very few side effects and is safe in children. It is 
used  in  treatment  of  refractory  seizures,  in  cranio-cerebral  injuries  and  strokes.  Its 
efficacy  in  treatment  of  aphasia  and  other  behavioural  abnormalities  (cognitive 
disorders) has also been studied.
MECHANISM
Piracetam  participates  in  the  activity  of  the  majority  of  neurotransmitters, 
increases glucose and oxygen consumption in the ischemic nervous tissue and increases 
blood flow through cerebral terminal vessels. In cranio-cerebral injuries, it is found to 
improve  cerebral  blood  flow.  Piracetam  is  also  found  to  increase  the  inhibitory 
hyperpolarising process in a manner similar to that of GABA.23,30
PACEMAKER IMPLANTATION
Kelly A. M. et al., showed usefulness of pacemakers in the treatment of severe 
breath holding spells associated with significant bradycardia25. They treated ten pediatric 
patients  with  apparent  breath  holding  spells  with  bradycardia  with  a  permanent 
ventricular  demand  pacemaker  at  the  Mayo  Clinic  USA  between  1985  and  1995. 
Permanent ventricular demand pacemakers were implanted at 10 months to 5 years of 
age. At follow up of 38 to 170 months (median 65.5), 5 patients had complete resolution 
of  spells,  2  had  only  mild  colour  change  without  loss  of  consciousness  or  seizure 
activity, and 3 continued to have minor brief spells. The study concluded that pacemaker 
implantation  for  children  with  pallid  breath  holding  spells  associated  with  severe 
bradycardia is safe, efficacious and warranted.
In  another  prospective  study,  Villain  E.  et  al.,  paced  11 children  with  severe 
breath holding spells26. The results were spectacular with disappearance of spells and 
restoration of normal activities. 2 patients were lost to follow up and only 5 were still 
vagotonic.  The  study  concluded  that  pacemaker  implantation  is  very  effective  in 
suppressing symptoms in severely affected children. 
REVIEW OF LITERATURE
Bhatia M. S. et al., (1990) evaluated 50 children with the diagnosis of BHS so as 
to find out the socio-demographic profile, role of parental attitudes and iron deficiency23. 
Of 50 preschool children having BHS, 80 % were less than 18 months of age (mean 16 
months). More children came from lower social class (70%) and a nuclear family (65%). 
Boys to girls ratio was 3:1. 48 (96%) children had cyanotic type of BHS and 2 (4%) had 
pallid  type of  BHS.  Tonic  and clonic  spasms were present  in  84% children.  Ninety 
percent children had spells when angry or frustrated, followed by 10% associated with 
falls. Majority of the children had frequency of spells as 1-3 attacks per week with a 
minimum of one per month and maximum of 12 per day.
The study did not find any significant association between the parental attitudes 
(measured on Attitude Screening Questionnaires) and BHS. No significant differences 
could be found as far as behaviour related to feeding, toilet and sleep were concerned. 
But  the children with BHS had problems in socialisation and more children reacted 
strongly to the environment. They were more demanding and irritable in nature, difficult 
to soothe and could not be left alone in a new situation. Associated behavioal problems 
like pica (16%),  thumb sucking (14%), nail  biting (10%),  head banging (8%),  sleep 
disturbances, hyperkinesis (8%), tics (6%), enuresis (4%) and stammering (6%) were 
detected in many children with BHS but they were not significantly more in comparison 
to the controls.
Mean haemoglobin in the study group was 8.12 g/dL as compared to 9.92 g/dL in 
the control group. The difference was statistically significant (p<0.01). Mean serum iron 
levels and percentage saturation of transferring were significantly lower in the study 
group compared to those in  the control  group.  In  96% of cases in the study group, 
peripheral  smear  showed either  hypochromic microcytic  or  hypochromic  normocytic 
anemia. 82% cases responded to oral therapy within  two weeks. After three weeks of 
therapy, all the cases showed improvement (either decrease in the severity or frequency 
of spells). 
DiMario F. J. Jr (2000) in a prospective cohort study of 95 children with cyanotic 
and pallid BHS, documented the natural history of spells31. A structured interview was 
undertaken  at  the  time  of  initial  consultation  and  at  subsequent  one  year  intervals 
regarding the type of BHS, frequency of spells, associated phenomena, sequelae, family 
history, and age at termination of spells. Of 95 children, 48 were boys and 47 were girls. 
All children were followed over a 9 year interval. Median age of onset was between 6 
and 12 months with 15% presenting younger than 6 months. A median frequency of 
spells was weekly with 30% experiencing 10 or more spells per day. The median age at 
peak frequency was between 12 and 18 months of age. Of the patients who remitted for 
>12 months (n=67), the last spell had occurred at a median age of 37 to 42 months. 
Hypoxic convulsions were associated with BHS in < 15% of all participants. A positive 
family  history  of  BHS was identified  in  34%,  with equal  distribution between both 
paternal and maternal sides.
Mocan H. et al., (1999) evaluated the prognosis of BHS after iron treatment in 91 
children aged between 6 months and 40 months24. All cases were followed prospectively 
for a median of 45 months. In 49 children, the frequency of BHS was less than 10 each 
month, in 22 it was 10 – 30 each month and in 20 it was more than 30 each month. The 
spell was cyanotic in 60 children, pallid in 9 and mixed type in 22 children. All patients 
were evaluated initially and during follow up for haematological indices. 63 patients 
were found to be have iron deficiency anemia and were treated with iron (6mg/kg/day) 
for three months. Other patients were not given any treatment. After the three months, 
there was a significant difference for correction of cyanotic spells between children who 
were treated with iron and those who were not (84.17 vs 21.4 %). Positive family history 
of BHS was found in 9 (10%) of patients24.
Donma M. M. et al., (1998) evaluated the efficacy of piracetam in the treatment of 
76 children with breath holding spells23. It was a randomised blind placebo–controlled 
study. Piracetam was given in a dose of 40 mg/kg/day in two divided doses daily for two 
months. Children were evaluated after two months, and then at three- month intervals. 
After  2  months,  the  number  of  breath  holding  episodes  per  month  decreased 
significantly  in  the  piracetam-treated  group.  92.3%  of  piracetam-treated  children 
remained symptom-free during the next six months after completion of treatment. No 
major  side  effect  was  observed.  The  author  concluded  that  piracetam is  a  safe  and 
effective treatment option for the patients of BHS.
A study was done by Azam et al., to assess the role of piracetam in severe breath 
holding spells. Fifty-two children were enrolled in the study, 34 boys and 18 girls. Ages 
ranged from 4 weeks to 5 years with mean age of 17 months. In 81% of children, spells 
disappeared completely and in 9% frequency was reduced to less than one per month 
and of much lesser intensity. Prophylaxis was given for 3-6 months (mean 5) duration. 
The authors concluded that piracetam was an effective prophylactic treatment for severe 
BHS30.
STUDY JUSTIFICATION
Breath  holding spells  are  often  benign,  but  fairly  common disorders  affecting 
children. Various underlying autonomic nervous system abnormalities and brain stem 
dysfunction have been implicated recently in the pathogenesis of these spells. Rarely, 
life-threatening events such as status epilepticus and prolonged bradycardia or asystole 
may occur. But till date, research into available drug therapy has remained inadequate. 
Various drugs such as diazepam, sodium valproate, carbamazepine and phenobarbitone 
have been used based on sporadic reports of usefulness or for their anticonvulsant effect. 
Iron therapy has been found to reduce the frequency of spells in anaemic children with 
BHS. Piracetam is a new drug on the horizon. Few studies have been conducted in India. 
This study has been undertaken to study the clinical  profile of BHS in the children 
attending our outpatient department, and to assess the role of diazepam and piracetam in 
the management of BHS. This study has been undertaken after obtaining the approval of 
the institutional review board in our hospital.
AIM OF THE STUDY
1. To study the clinical profile of children with breath holding spells
2. To study the role of diazepam and piracetam in the management of breath holding 
spells
SUBJECTS AND METHODS
STUDY DESIGN : Randomized controlled trial
STUDY POPULATION: Children  attending  the  Neurology  OP  or  the  Child 
Guidance Clinic at ICH & HC, Chennai, and diagnosed 
as breath holding spell by history.
STUDY PERIOD : November  2006  to  October 
2008 
SAMPLE SPECIFICATION :
Inclusion criteria
Children aged 1month to 5 years with history suggestive of breath holding spell as 
follows:-
Antecedent  provocative  event  (anger/frustration/pain/fear)  crying,  progressively 
increasing in intensity  → point of noiselessness  → colour change (cyanosis/pallor)  → 
resolution  of  features  or  loss  of  consciousness  with  or  without  seizure-like  activity 
followed by resolution.
Exclusion criteria
Underlying cardiac disease
Underlying CNS pathology
Primary lung pathology
Sample size
Assuming an improvement of atleast 40% in the study groups as compared to the 
control group, and the power of the study to be 85%, sample size was calculated to be 30 
per group, with a total of 90 cases.
PROPOSED METHODOLOGY:
90 children diagnosed to have breath holding spells by history and satisfying the 
study criteria were included in  the study after  obtaining written parental  consent.  A 
structured interview was conducted at the time of enrolment into the study (Proforma 
included in  the Annexure).  A complete  physical  examination was done and cardiac, 
neurological and respiratory diseases excluded clinically. EEG was taken to rule out true 
seizures. If the EEG was abnormal, the child was excluded from the study.
The children were then randomly allotted into one of the three groups- A, B or C 
using  computer-generated  random numbers.  A baseline  haemoglobin  estimation  was 
done to look for the presence of anemia in all children. Parental counselling was done 
regarding BHS, its treatment and prognosis. They were also given a patient information 
form containing  information  about  breath  holding spells.  They were also  advised  to 
maintain a spell diary everyday for information regarding number of spells per day.
Children allocated to Group A were given oral Diazepam 0.1 mg/kg/day in one or two divided 
doses.
Children in Group B were given oral Piracetam in a dose of 40 mg/kg/day in two divided doses.
Children in Group C did not receive either of these drug and were considered as the control 
group.
Children in all the three group with haemoglobin less than 11 mg/dL were also given oral iron 
in the form of ferrous sulphate at a dose of 6 mg/kg/day of elemental iron.
The total duration of theray was three months. During this period, children were reviewed every 
two weeks. The spell diary was seen to record the number of spells, and certain review questions asked 
(Follow up Questionnaire in Annexure). Drugs were issued once in two weeks at the time of review.
After completion of therapy, the children were followed up for one year, initially monthly visits 
for three months and then 3-monthly visits till the end of one year. A minimum of 3 visits was required 
to document adequate follow up; those with fewer visits were considered to be lost to follow up. 
Children with 50% or more reduction in the frequency of spells at completion of treatment were 
considered as cured. At completion of therapy, haemoglobin estimation was repeated to look for 
improvement in the haemoglobin status in these children.
If the child developed adverse reactions to the drug under study, or had a >50% increase in 
frequency of spells than at the time of enrolment into the study, he/she would be withdrawn from the 
study.
STATISTICAL METHODS FOR ANALYSIS OF RESULTS
All statistics were analysed using SPSS10 and EPI INFO software. Comparison of baseline 
characteristics was done using Chi Square Test. Pre – and Post treatment data were analysed using one-
way ANOVA. Paired groups of data were analysed using Paired ‘t’ test. More than one group was 
analysed using ANOVA.
OBSERVATIONS
Total number of children with breath holding spells initially screened was 98. Out 
of this, 8 children (8.16%) were found to have abnormal EEG and hence were excluded 
from the study.
90 children were enrolled in the study after obtaining written parental consent. An 
information brochure regarding BHS was also handed over to the parents.
Table 1:  AGE AT ONSET
AGE
(IN MONTHS)
GROUP A
N (%)
GROUP B
N(%)
GROUP C
N(%)
OVERALL
N(%)
< 12 18 (60.0%) 15 (50.0%) 12 (40.0%) 45 (50.0%)
13 – 24 8 (26.7%) 11(36.7%) 9 (30.0%) 28 (31.1%)
25 –36 4 (13.3%) 4 (13.3%) 8 (26.7%) 16 (17.8%)
37 – 48 0 (0%) 0 (0%) 1 (3.3%) 1 (1.1%)
TOTAL 30 30 30 90
Out of the 90 children studied, 50% had onset of breath holding spells before one 
year of age, with 7 out of 90 children (7.7%) having onset before 6 months of age (Table 
1).
Table 2: SEX DISTRIBUTION
SEX GROUP A
N (%)
GROUP B
N(%)
GROUP C
N(%)
OVERALL
N(%)
MALE 20 (66.7%) 20 (66.7%) 15 (50%) 55 (61.1%)
FEMALE 10 (33.3%) 10 (33.3%) 15 (50%) 35 (38.9%)
TOTAL 30 30 30 90
The overall  male: female ratio was found to be 1.6:1, indicating a slight male 
preponderance (Table 2).
Table 3: SPELL TYPE
SPELL 
TYPE
GROUP A
N (%)
GROUP B
N(%)
GROUP C
N(%)
OVERALL
N(%)
CYANOTIC 21 (70%) 20 (66.7%) 21 (70%) 62 (68.9%)
PALLID 5 (16.7%) 7 (23.3%) 7 (23.3%) 19 (21.1%)
MIXED 4 (13.3%) 3 (10.0%) 2 (6.7%) 9 (10.0%)
TOTAL 30 30 30 90
Cyanotic breath holding spells were seen in 68.9% of children and is the most 
common type of BHS. Pallid spells were seen in 21.1% of children, while both types of 
spells were seen in 10.0% of children (Table 3) .
Table 4: FREQUENCY OF SPELLS
NO.OF 
SPELLS 
PER WEEK
GROUP 
A
GROUP 
B GROUP C OVERALL
< 1 15 (50.0%) 13 (43.3%) 15 (50.0%) 43 (47.8%)
1 -3 9 (30.0%) 14 (46.7%) 8 (26.7%) 31 (34.4%)
4 -6 2 (6.7%) 1 (3.3%) 4 (13.3%) 7 (7.8%)
7 -10 2 (6.7%) 1(3.3%) 0 (0.0%) 3 (3.3%)
>10 2 (6.7%) 1 (3.3%) 3 10.0%) 6 (6.7%)
TOTAL 30 30 30 90
Maximum number of children (47.8%) had less than one episode per week. 34.4% 
of the children had between 1 to 3 episodes per week. About 6.7% of children had more 
than 10 episodes per week (Table 4).
Table 5: SEVERITY OF SPELLS
SEVERITY OF 
SPELL
GROUP A 
N (%)
GROUP B 
N (%)
GROUP C 
N (%)
OVERALL
N (%)
SIMPLE 26 (86.7%) 23 (76.7%) 26 (86.7%) 75 (83.3%)
SEVERE 4 (13.3%) 7 (23.3%) 4 (13.3%) 15 (16.7%)
LIFE-
THREATENING
0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
TOTAL 30 30 30 90
83.3%  of  children  had  simple  breath  holding  spells  without  seizure  activity. 
16.7% of children developed hypoxic seizures at the end of the episode. None of the 
children in the study had life-threatening events such as status epilepticus or cardiac 
arrest requiring emergency medical intervention (Table 5). 
Table 6: PRECIPITATING FACTORS
FACTOR GROUP A
N (%)
GROUP B
N (%)
GROUP C 
N (%)
OVERALL
N (%)
ANGER 16 (53.3%) 17 (56.7%) 19 (63.3%) 52 (57.8%)
PAIN 16 (53.3%) 18 (60.0%) 17 (56.7%) 51 (56.7%)
FEAR 7 (23.3%) 15 (50.0%) 5 (16.7%) 27 (30.0%)
>1 FACTOR 9 (30.0%) 17 (56.7%) 10 (33.3%) 36 (40%)
Anger  (57.8%)  was  the  most  common  factor  precipitating  the  occurrence  of 
breath holding spells, followed by pain (56.7%). Fear was the cause in 30% of children. 
More than one factor was implicated in 40% of children (Table 6). 
Table 7: ASSOCIATED BEHAVIOURAL DISTURBANCES
GROUP A
N (%)
GROUP B
N (%)
GROUP C
N (%)
OVERALL
N (%)
PICA 6 (20%) 6 (20%) 11 (36.7%) 23 (25.6%)
THUMB-
SUCKING
7 (23.3%) 11 (36.7%) 10 (33.3%) 28 (31.1%)
NAIL-BITING 1 (3.3%) 0 (0.0%) 2 (6.7%) 3 (3.3%)
HEAD 
BANGING
9 (30%) 14 (46.7%) 8 (26.7%) 31 (34.4%)
INCESSANT 
CRY
5 (16.7%) 4 (13.3%) 5 (16.7%) 14 (15.6%)
TEMPER 
TANTRUMS
10 (33.3%) 12 (40.0%) 12 (40%) 34 (37.8%)
>1 FACTOR 11 (36.7%) 15 (50.0%) 13 (43.3%) 39 (43.3%)
Behaviour disturbances were noted in 73 out  of  90 children (81%).  The most 
common behaviour disturbance in these children was temper tantrums (37.8%), followed 
by head banging (34.4%). Thumb sucking was noted in 31.1%, pica in 25.6%, incessant 
cry  in  15.6%  and  nail  biting  in  3.3%  of  the  children.  More  than  one  behaviour 
disturbance was noted in 43.3% of the children (Table 7).
Table 8: TYPE OF FAMILY
TYPE OF 
FAMILY
GROUP A
N (%)
GROUP B
N (%)
GROUP C
N (%)
OVERALL
N (%)
JOINT 8 (26.7%) 11 (36.7%) 14 (46.7%) 33 (36.7%)
NUCLEAR 22 (73.3%) 19 (63.3%) 16 (53.3%) 57 (63.3%)
TOTAL 30 30 30 90
63.3% of children with breath holding spells came from a nuclear family, while 
36.7% lived in a joint family (Table 8). 
Table 9: FAMILY HISTORY
GROUP 
A
GROUP 
B
GROUP 
C
OVERALL
BREATH-
HOLDING SPELL
1 0 5 6
SEIZURE 1 0 3 4
A positive family  history of  breath holding spells  was present  in 6  out  of  90 
children (6.7%).  4  out  of  90 children also  had a  positive family  history of  seizures 
(4.4%) (Table 9).
Table 10: PRESENCE OF CLINICAL PALLOR AND ANEMIA
GROUP A
N (%)
GROUP B
N (%)
GROUP C
N (%)
OVERALL
N (%)
PALLOR 8 (26.7%) 9 (30.0%) 10 (33.3%) 27 (30.0%)
ANEMIA 24 (80.0%) 20 (66.7%) 21 (70.0%) 65 (72.2%)
NO ANEMIA 6 (20.0%) 10 (33.3%) 9 (30.0%) 25 (27.8%)
TOTAL 30 30 30 90
 
Clinically, pallor could be made out in 30% of the children, whereas 72.2% of the 
children  had  anemia  as  evidenced  by  hemoglobin  less  than  11g/dL.  27.8%  of  the 
children had haemoglobin 11g/dL or more (Table 10).
The frequency of breath holding spells was assessed at the time of enrolment into 
the study, at the completion of three-month treatment period, and during follow up for 
two years. One child in Group B was lost to followup.
Table 11: COMPARISON OF REDUCTION IN FREQUENCY OF 
SPELLS AT COMPLETION OF TREATMENT AND AT FOLLOW-UP 
AMONG THE THREE GROUPS
 
 
GROUP
A B C
Mean SD Mean SD Mean
SD
Oneway 
ANOVA F-
test
REPEATED 
MEASURES OF 
ANOVA
FREQ of spells 
pre-treatment 3.29 3.96 3.17 4.60 3.83 6.10
F=0.15 
P=0.86
FREQ of spells 
at  completion 
of treatment
1.80 2.66 1.86 3.65 2.27 3.53 F=0.18 P=0.84
FREQ of spells 
at  3  months 
follow up
.53 1.14 .41 1.35 .57 1.52 F=0.11 P=0.90
FREQ of spells 
at  1  yr  follow 
up
.13 .43 .07 .37 .13 .57 F=0.19 P=0.83
Within 
group 
F=48.33 
P=0.001
Between group
F=0.13 P=0.88
 One  way 
ANOVA
F=48.71 
P=0.001
F=6.68 
P=0.001
F=6.60 
P=0.001
Prior to treatment, the mean frequency of spells per week in Group A was 3.29. 
The mean frequency of spells in Group B was 3.17. The mean frequency of spells in 
Group  C  was  3.83.  The  three  groups  were  comparable  with  respect  to  baseline 
characteristics (Table 11).
On completion of  treatment,  the mean frequency was 1.80 spells  per  week in 
Group A, 1.86 in Group B and 2.27 in Group C. The mean frequency of spells was 
lower in Groups A and B, but this difference was not statistically significant.
Following treatment for three months, the mean frequency of spells decreased by 
45% in Group A, 41% in Group B and 41% in Group C. Though the reduction was more 
in the Diazepam group, it was not found to be statistically significant (p =0.88).
At the end of one year of follow up, the mean frequency of spells per week was 
0.13 in Group A, 0.07 in Group B and 0.13 in Group C. The difference between the 
groups was not statistically significant.
(Fig. 10) Comparison of reduction in frequency of spells at 
completion of treatment and at follow-up among the three groups
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The number of children who could be considered cured as evidenced by reduction 
in spell frequency by atleast 50% at the end of treatment was 76.7% in Group A, 93.3% 
in  Group  B  and  90%  in  Group  C.  The  difference  was  not  statistically  significant 
(P=0.55) (Fig. 10).
Table 12: COMPARISON OF MAXIMUM SPELL-FREE PERIOD BETWEEN 
THE THREE GROUPS
N Mean Std. Deviation
One way 
ANOVA F-test
A 30 8.70 4.178
B 29 10.31 3.516
C 30 10.33 3.745
Total 89 9.78 3.861
F=1.79 P=0.17
The mean maximum spell-free interval was found to be 8.70 months in Group A, 
10.31 months in Group B and 10.33 months in Group B. This was analysed by one- way 
ANOVA and it was found that there was no statistically significant difference between 
the three groups (Table 12).
During treatment period no adverse drug reactions or problems were complained 
of. During follow up, one child in Group C was admitted for bronchopneumonia and 
was discharged after 7 days following clinical improvement.
Table 13: COMPARISON OF PRE- & POST- TREATMENT HEMOGLOBIN 
CONCENTRATION AMONG THE THREE GROUPS 
Group Mean
Std. 
Deviation
Student 
paired t-test
A
Pre-Treatment HB
10.01 1.124
Post-Treatment HB 11.65 .761
t=15.68 
P=0.001
B Pre-Treatment HB 10.11 1.361
Post-Treatment HB 11.72 1.097
t=16.36 
P=0.001
C Pre-Treatment HB 10.22 1.164
 Post-Treatment HB 11.83 .810
t=16.82 
P=0.001
The mean pre-treatment haemoglobin in Group A was 10.1g/dL, in Group B was 
10.11g/dL  and  in  Group  C  was  10.22g/dL.  After  the  completion  of  treatment, 
haemoglobin levels were reassessed. The mean haemoglobin in Group A was 11.65g/dL, 
in Group B was 11.72g/dL and in Group C was 11.83g/dL. There was no statistically 
significant difference between the three groups (p=0.86) (Table 13).
Table 14: COMPARISON OF MEAN RISE IN HEMOGLOBIN CONCENTRATION AMONG THE 3 GROUPS
N Mean Std. Deviation
One way ANOVA F-test
A
30 1.60 .548
B 29 1.61 .530
C 30 1.61 .524
Total 89 1.61 .528
F=0.02 P=0.99
The mean rise in haemoglobin was 1.60g/dL, 1.61g/dL and 1.61g/dL in Group A, 
Group B and Group C respectively. The difference between the three groups was not 
statistically significant (Table 14).
DISCUSSION
In our study, out of 90 children with breath holding spells studied, the median age 
of onset was 12.46 months (range 4 months to 4 years). In the studies by Bhatia M. S, et 
al.,23 Mocan H et al.,24 and Anil B. G et al.15 the mean age of onset was 9.6 months, 17 
months and 14.2 months respectively. In our study, 45 children (50%) had onset of BHS 
before one year of age, with 7 children (7.7%) experiencing their first spell before six 
months of age. Bridge et al.1 and Lombroso and Lerman2 had reported the age of onset 
from the neonatal period to about four years.
In our study, out of 90 children, there was a male preponderance with a male: 
female ratio of 1.6:1. This is similar to earlier studies by Bhatia M. S. et al.19 (M:F=3:1), 
Mocan H et al.20 (M:F=1.6:1) and Anil B. G. et al.15 (3:2). But DiMario has reported 
equal incidence of BHS in both sexes in his study.
68.9% of children in our study had cyanotic type of BHS, 21.1% had pallid type 
while 10.0% had mixed type of spells. In the study by Bhatia M. S. et al.19, 96% had 
cyanotic type while 4% had pallid type of BHS.
Lombroso and Lerman2, Livingston1, Bhatia M. S. et al.19 and Anil B. G. et al 
have reported tonic-clonic convulsions in 46%, 49%, 84% and 82% respectively. In our 
study,  convulsions were observed in  16.7% of the children.  None of  them had life-
threatening events like status epilepticus or cardiac arrest.
47.8% of the children in our study had less than 1 spell per week, followed by 
34.4% of children with 1-3 spells per week. 6.7% of children had more than 10 spells 
per week. In the study by Anil B. G. et al.15, they have reported 58% of children had 
frequency of spells as 1-3 per week. Bhatia M. S. et al.19 also have reported in their study 
that majority of the children had frequency of spell as 1-3 per week.
In our study, anger was the triggering factor in the majority of children (57.8%), 
followed by fear (56.7%). Pain was the triggering factor in 30% of the children. More 
than one factor was implicated in 40% of the children in our study. In the study by Anil 
B. G. et al.15, anger or frustration were the triggering factors in 82% of children followed 
by fall (14%), and fear or pain (4%).
As reported by Bakwin and Bakwin5, Bhatia M. S. et al.19 and Anil B. G. et al.15, 
several behaviour problems have been reported in our children also. The most common 
behaviour disturbance in these children was temper tantrums (37.8%), followed by head 
banging (34.4%). More than one problem was present in 43.3% of the children in our 
study.
63.3% of children with breath holding spells came from a nuclear family, while 
36.7% lived in a joint family. 
A positive family  history of  breath holding spells  was present  in 6  out  of  90 
children (6.7%).  4  out  of  90 children also  had a  positive family  history of  seizures 
(4.4%). In the study by DiMario F. J.  Jr.16,  21% of the siblings and 27% of parents 
reported either current or past history of BHS.
Clinically, pallor could be made out in 30% of the children, whereas 72.2% of the 
children  had  anemia  as  evidenced  by  hemoglobin  less  than  11g/dL.  27.8%  of  the 
children had haemoglobin 11g/dL or more.
Prior to treatment, the mean frequency of spells per week in Group A was 3.29. 
The mean frequency of spells in Group B was 3.17. The mean frequency of spells in 
Group  C  was  3.83.  The  three  groups  were  comparable  with  respect  to  baseline 
characteristics (p value>0.5).
The three Groups were again compared following completion of treatment. None 
of the children were withdrawn from the study on account of adverse reaction to the 
drugs used. One child in Group B was lost to follow up.
On completion of  treatment,  the mean frequency was 1.80 spells  per  week in 
Group A, 1.86 in Group B and 2.27 in Group C. The mean frequency of spells was 
lower in Groups A and B, but this difference was not statistically significant.
Following treatment for three months, the mean frequency of spells decreased by 
45% in Group A, 41% in Group B and 41% in Group C. Though the reduction was more 
in the Diazepam group, it was not found to be statistically significant (p= 0.88).
At the end of one year of follow up, the mean frequency of spells per week was 
0.13 in Group A, 0.07 in Group B and 0.13 in Group C. The difference between the 
groups was not statistically significant.
The number of children who could be considered cured as evidenced by reduction 
in spell frequency by atleast 50% at the end of treatment was 23 (76.7%) in Group A, 28 
(93.3%) in Group B and 27(90%) in Group C. Though more children appeared to be 
cured  in  Group  A  as  compared  to  the  other  two  groups,  the  difference  was  not 
statistically significant (p= 0.55).
The mean maximum spell-free interval was found to be 8.70 months in Group A, 
10.31 months in Group B and 10.33 months in Group B. This was analysed by one- way 
ANOVA and it was found that there was no statistically significant difference between 
the three groups.
In  the  study  conducted  by  Donma23,  placebo  or  piracetam as  suspension  was 
administered to patients on a randomized basis; piracetam was administered to children 
in suspension 40 mg/kg/day in 2 divided doses for a period of 2 months.  Of the 76 
children enrolled, 39 received piracetam and 37 received placebo. Overall, control of 
breath-holding  spells  was  observed  in  92.3%  of  the  patients  in  the  group  taking 
piracetam as compared with 29.7% in the group taking placebo (p<0.5).
A similar study was done by Azam M et al.30. Fifty-two children were enrolled in 
the study, 34 boys and 18 girls. Ages ranged from 4 weeks to 5 years with mean age of 
17 months. Prophylaxis was given for 3 to 6 months Piracetam was prescribed to those 
children who were diagnosed as severe BHS in a dose ranging from 50-100 mg/kg/day, 
which is a higher dose than that  used in our study.  Iron supplements were added if 
hemoglobin was less than 10 gm%. Patients were seen at 2-4 weeks interval and follow-
up was continued until 3 months after the cessation of drug therapy. In 81% of children, 
spells disappeared completely and in 9% frequency was reduced to less than one per 
month and of much lesser intensity.
There is  no comparable trial  previously done for  the role of diazepam. In our 
study, iron was also prescribed to children who were anemic, since there are several 
trials  documenting  the  efficacy  of  iron  in  reducing the  frequency  of  breath  holding 
spells.  The use of iron in anemic breath holders in all  3 groups has probably led to 
comparable reduction in spell frequency and cure rates among all 3 groups.
SUMMARY AND CONCLUSION
• Half the children had onset of spells before one year of age.
• There was a male preponderance in the occurrence of spells noted in our study.
• 68% of spells were cyanotic type.
• Tonic-clonic movements were present in 16% of children with BHS in our study.
• 47% of children had frequency of  spells  less than one per  week and 6.7% of 
children had more than 10 spells per week. 
• Anger and pain were the most common triggering factors in 57.8% and 56.7% of 
children, respectively.
• Behaviour  abnormalities  were  reported  in  81%  of  the  children,  with  temper 
tantrums being the most common (37.8%).
• A positive family history of BHS was present in 6.7% of the children only.
• There  was  a  significant  reduction  in  the  frequency  of  spells  in  each  group 
following  treatment,  but  the  there  was  no  statistically  significant  difference 
between the groups.
• The cure rate following treatment was also comparable among the three groups.
• Neither diazepam nor piracetam was found to produce a statistically significant 
maximum spell-free interval more than the control group.
• The mean haemoglobin levels, pre- and post- treatment were comparable in all 
three groups.
From this study, we conclude that the role of diazepam and piracetam was not 
found to be significant as compared to the control group, though there are reports to the 
contrary. The role of diazepam or piracetam in the sub group of children with severe 
breath holding spells has to be studied. Further studies with a larger study population or 
in children with severe breath holding spells would be required before we can arrive at a 
definite conclusion.
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PATIENT INFORMATION FORM
What are breath-holding spells?
Breath-holding spells are considered to be a behavioural disorder in children. This is fairly common, 
occurring in upto 27% of otherwise healthy children, and may be severe in about 0.1 – 4.6% of 
children. This commonly occurs in children between six months to five years and has been found to 
subside on its own as the child grows.
How to recognise a spell?
When a child is provoked as being refused chocolates or scolded for a mischief, or following painful 
stimulation such as injections, he/ she starts crying. This increases to a point of noiselessness, where 
the child’s breathing stops in expiration. He turns blue or pale, and becomes limp.the child may lose 
consciousness, and develop jerking of limbs similar to a seizure. After a few minutes, he regains 
consciousness.
What should be done during a spell?
The child must be placed in a lying posture in a safe place. If there is jerking of limbs, the child must be 
turned to one side, and adjacent sharp objects removed, so that he does not get hurt. If the child is not 
breathing or does not recover in five minutes, medical help must be sought.
What must not be done?
When the child develops a spell, he must not be picked up and fondled. Any unfair demands must not 
be fulfilled in order to prevent a spell. If done so, this behaviour is reinforced, and becomes difficult to 
control.
Is there any treatment for breath-holding spells?
Behaviour modification forms the basis of treatment. It is important for the parents to 
avoid fondling or hugging the child following a spell. Iron supplementation has been 
found to be useful in anemic children. Certain drugs have been found useful in control of 
spells,  primarily  by  their  effect  in  calming  the  child.  If  the  spells  are  severe,  with 
continuing  seizures,  or  prolonged  unresponsiveness,  immediate  medical  attention  is 
essential.
ROLE OF DIAZEPAM AND PIRACETAM IN THE MANAGEMENT 
OF BREATH-HOLDING SPELLS
PATIENT DATA ENTRY FORM
PATIENT DETAILS :
Name
Age / Sex
Address and contact number
Informant 
CGC No / Neurology No
STUDY NO AND GROUP -
HISTORY :
Age at onset
Type of spell – 
1. Cyanotic
2. Pallid
3. Mixed
Frequency per week –
c. <1
d. 1-3
e. 4-6
f. 7-10
g. >10
Severity of spell – 
1. Simple
2. Severe
3. Life – threatening
Precipitating factors – 
1. Anger
2. Pain
3. Fear
Associated behaviour disturbance –
g. Pica
h. Thumb-sucking
i. Nail biting
j. Head-banging
k. Incessant cry
l. Temper tantrums
m. Other (specify)
Maternal history – 
1. Maternal illness
2. Drug intake
3. Others (specify)
Perinatal history – 
1. Birth asphyxia
2. Neonatal seizures
3. Others (specify)
Developmental milestones – 
1. Normal
2. Delayed 
Type of family –
1. Joint
2. Nuclear
Family history of BHS –
1. Yes 
2. No 
Family history of seizures –
1. Yes 
2. No 
CLINICAL ASSESSMENT :
Physical examination –
Pallor –
1. Yes 
2. No
System examination – 
1. Normal
2. Abnormal 
If any abnormality detected, please specify
Haemoglobin  -
1. >  11g/dL
2. <11 g/dL
EEG – 
1. Normal
2. Abnormal
Additional details, if any
FOLLOW UP QUESTIONNAIRE
During therapy –
1. Did the child have any BHS since the last visit? Yes/ no
2. How many episodes per week ?  <1 /1-3/ 4-6/ 7-10/ >10
3. Severity of the episode – simple/ severe/ life threatening
4. Other significant problem or illness since the last visit? Yes / no
5. Whether drug compliance was good? Yes/ no
6. Any adverse drug reactions? Yes / no, if yes, specify
After completion of therapy-
1. Did the child have any BHS since the last visit? Yes/ no
2. How many episodes per week? <1/ 1-3/ 4-6/ 7-10/ >10
3. How severe was the episode – simple/ severe / life threatening
Investigations- 
• Haemoglobin level on completion of therapy : <11 g/dL , > 11g/dL
